1. Home
  2. CUBI vs DNLI Comparison

CUBI vs DNLI Comparison

Compare CUBI & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$74.44

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$18.74

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBI
DNLI
Founded
1994
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.4B
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
CUBI
DNLI
Price
$74.44
$18.74
Analyst Decision
Buy
Strong Buy
Analyst Count
11
20
Target Price
★ $93.55
$36.06
AVG Volume (30 Days)
243.4K
★ 1.7M
Earning Date
10-22-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 22.99
N/A
EPS
★ 4.02
N/A
Revenue
N/A
N/A
Revenue This Year
$6.60
N/A
Revenue Next Year
$11.86
$156.11
P/E Ratio
$18.56
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.34
$13.75
52 Week High
$84.38
$27.30

Technical Indicators

Market Signals
Indicator
CUBI
DNLI
Relative Strength Index (RSI) 37.67 28.34
Support Level $72.04 $18.38
Resistance Level $79.75 $20.84
Average True Range (ATR) 1.57 0.81
MACD -0.20 -0.08
Stochastic Oscillator 36.26 8.45

Price Performance

Historical Comparison
CUBI
DNLI

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: